4DMedical Ltd (AU:4DX) has released an update.
4DMedical Ltd, a leader in respiratory imaging technology, has announced an investor webinar for May 10, 2024, where the CEO, Dr Andreas Fouras, will cover the company’s recent updates. The webinar will showcase 4DMedical’s advancements in lung health diagnostics, including their FDA-cleared XV Technology® for lung function analysis. 4DMedical has recently expanded its capabilities by acquiring Imbio, a company specializing in AI medical imaging for lung and cardiothoracic diseases.
For further insights into AU:4DX stock, check out TipRanks’ Stock Analysis page.
